SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties
Miquel Oliu-Barton
(1)
,
Bary Pradelski
(2, 3)
,
Philippe Aghion
(4, 5, 6, 7, 8)
,
Patrick Artus
(9, 7)
,
Ilona Kickbusch
(10)
,
Jeffrey Lazarus
(11)
,
Devi Sridhar
(12)
,
Samantha Vanderslott
(13)
1
Université Paris Dauphine-PSL
2 POLARIS - Performance analysis and optimization of LARge Infrastructures and Systems
3 Oxford-Man - Oxford-Man Institute of Quantitative Finance
4 CdF (institution) - Collège de France
5 LSE - London School of Economics and Political Science
6 INSEAD - Institut Européen d'administration des Affaires
7 PSE - Paris School of Economics
8 PJSE - Paris Jourdan Sciences Economiques
9 Natixis
10 IHEID - Graduate Institute of International and Development studies
11 ISGlobal - Instituto de Salud Global - Institute For Global Health [Barcelona]
12 Usher Institute of Population Health Sciences and Informatics [Edinburgh, U.K.]
13 Oxford Vaccine Group
2 POLARIS - Performance analysis and optimization of LARge Infrastructures and Systems
3 Oxford-Man - Oxford-Man Institute of Quantitative Finance
4 CdF (institution) - Collège de France
5 LSE - London School of Economics and Political Science
6 INSEAD - Institut Européen d'administration des Affaires
7 PSE - Paris School of Economics
8 PJSE - Paris Jourdan Sciences Economiques
9 Natixis
10 IHEID - Graduate Institute of International and Development studies
11 ISGlobal - Instituto de Salud Global - Institute For Global Health [Barcelona]
12 Usher Institute of Population Health Sciences and Informatics [Edinburgh, U.K.]
13 Oxford Vaccine Group
Bary Pradelski
- Fonction : Auteur
- PersonId : 742675
- IdHAL : bary-pradelski
- ORCID : 0000-0003-2418-0037
Philippe Aghion
- Fonction : Auteur
- PersonId : 1360165
- IdHAL : philippe-aghion